SAPHETOR-SA
24.7.2024 09:01:28 CEST | Business Wire | Press release
Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing (NGS) data in compliance with the European Union’s In-Vitro Diagnostic Medical Devices Regulation (IVDR) (EU Regulation 2017/746 on IVD medical devices) by the notified body TÜV SÜD.
This represents a major milestone in clinical genomics, as robust standards and regulations are introduced to ensure the safety and effectiveness of medical devices. Inclusion of NGS analysis software under IVDR, is a reflection of the maturity of the technology and its importance in clinical practice. With this shift towards routine care, comes the need for transparency and reproducibly reliable performance.
IVDR, which came into full effect on 26 of May 2022, replaces the previous In-Vitro Diagnostic Medical Devices Directive (IVDD) and introduces more stringent requirements for the classification, performance evaluation, and post-market surveillance of in-vitro diagnostic devices. VarSome Clinical’s IVDR certification ensures that it meets the highest standards of safety, performance, and reliability.
As a result of IVDR coming into full effect, in-house tests (also known as Laboratory Developed Tests (LDTs)) or Research Use Only (RUO) products must comply with Article 5.5 of IVDR. This includes in particular the need to implement appropriate quality management systems, comply with the GSPR (General Safety & Performance Requirements) and set up a review process to take necessary corrective actions based on experience gained from the clinical use of the RUO product. At the end of the IVDR transition period, laboratories will no longer be allowed to use a RUO bioinformatics solution if an equivalent IVDR-certified product, such as VarSome Clinical, is commercially available.
Key benefits of VarSome Clinical’s IVDR certification:
- Enhanced safety and performance: VarSome Clinical has undergone rigorous performance evaluations, including scientific validity, analytical performance, and clinical performance, ensuring they meet the stringent requirements set forth by the IVDR.
- Improved risk management: The new risk-based system and comprehensive technical documentation provide a strong framework for identifying and reducing potential risks associated with in-vitro diagnostic devices.
- Strengthened market surveillance: With enhanced post-market surveillance measures, including vigilance reporting and periodic safety updates, Saphetor is committed to continuously monitor the performance and safety of VarSome Clinical.
- Transparency and traceability: Achieving better management of safety related issues and ensuring prompt actions when necessary.
- Regulatory excellence: VarSome Clinical’s IVDR certification demonstrates the dedication of Saphetor for regulatory excellence, providing confidence to healthcare professionals and patients in the quality and reliability of VarSome Clinical as a clinical diagnostic support solution.
Andreas Massouras, CEO and Founder, Saphetor SA, comments:
“The journey to IVDR certification has taken us more than two years. It has taken a lot of hard work across the company, and a lot of planning to put new processes in place. This now sets the new standard that all NGS diagnostic pipelines need to adhere to. Ensuring patient safety, through transparent and robust processes is crucial at this point in time. Genomic data is already having a major impact on healthcare, and so it is now critically important that it meet the standards that the rest of established medical practices have to meet. This is an exciting time, as it shows that genomics is now moving beyond clinical research and into routine clinical care. We are exceptionally proud to be amongst the first bioinformatics platforms to be awarded a CE mark under IVDR, and we look forward to continuing to help advance human health with our VarSome Clinical partners.”
Amélie Martinez, RAQA Director, Saphetor SA, comments:
“This certification is a great achievement and rewards all our efforts in meeting the IVDR requirements, both with the medical device documentation and our Quality Management System. We are proud to be able to provide Healthcare Professionals and diagnostic labs with an IVDR-compliant device, thus reducing their workload for process validation and giving them more time to care for patients.”
About Saphetor SA
Saphetor SA, is a global precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge.
Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com professional community and search engine is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 140 genetic and genomic data resources.
VarSome Premium and VarSome Clinical are professional editions of VarSome with powerful functionality and further sophisticated data-mining and analysis tools. VarSome Clinical is a IVDR-certified and HIPAA-compliant platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which helps clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions. VarSome can also be integrated into existing in-house pipelines via VarSome API through cloud-based or on premises installations.
For more information about Saphetor SA and VarSome Clinical, please visit www.saphetor.com or contact sales@varsome.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240724536462/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdspartneren Milestone Technologies19.3.2026 19:02:00 CET | Pressemeddelelse
Andersen Consulting fortsætter med at styrke sin platform for digital transformation med tilføjelsen af samarbejdspartneren Milestone Technologies, der er en veletableret global leverandør af it-services og digitale løsninger med base i USA. Milestone Technologies blev grundlagt i 1997 og leverer omfattende teknologi- og outsourcingløsninger, der spænder over digitale arbejdspladstjenester, cloud- og infrastrukturstyring, data, AI og automatisering, apps og digital engineering, business process outsourcing samt implementering af platforme som ServiceNow og Salesforce. Med hovedkontor i Fremont, Californien, opererer Milestone i 35 lande på globalt plan og samarbejder med nogle af verdens største virksomheder. Virksomhedens integrerede leveringsmodel gør det muligt for kunder at transformere deres it-drift, øge serviceeffektiviteten og skalere teknologiske økosystemer gnidningsfrit over hele verden. "Milestone Technologies er en medarbejderfokuseret organisation, der leverer målbare for
Klarna Card reaches 5 million active customers19.3.2026 15:31:00 CET | Press release
Klarna, the global digital bank and payments provider, today announced that the Klarna Card has reached 5 million active customers globally, underscoring rapid adoption as consumers shift towards new forms of payment which provide more control over day-to-day money management. The card draws from the customer's own funds for everyday spending, with the option to spread the cost of a specific purchase, like a large appliance or a flight, when it makes sense to do so. The result is a card that offers genuine spending control without the long-term debt obligations that come with traditional credit cards. The card’s growth is reinforced by Klarna’s membership program. The program offers premium perks such as airport lounge access, travel insurance, and lifestyle subscriptions — without requiring users to take on debt, meet spending thresholds, or revolve balances. By separating everyday spending from rewards, Klarna is challenging the strings-attached model legacy banks have long relied on
Stonebranch Releases 2026 Global State of IT Automation Report, Revealing Orchestration as the Missing Link for AI Adoption and Trust19.3.2026 14:30:00 CET | Press release
New research shows hybrid IT orchestration, automation-as-a-service, and WLA investments are accelerating as AI workflow deployment scales across the enterprise. Stonebranch, a leading provider of service orchestration and automation solutions, today released its annual 2026 Global State of IT Automation Report, the company’s most comprehensive research study to date. Based on responses from 402 IT automation professionals spanning C-suite executives to individual contributors across North America, EMEA, Latin America, and APAC, the report provides a detailed, data-driven portrait of how enterprises are investing in, deploying, and deriving value from IT automation in 2026. “This year’s findings highlight an important shift in how organizations approach automation,” said Giuseppe Damiani, CEO of Stonebranch. “Organizations are now building automation as strategic infrastructure — a governed, scalable foundation that spans hybrid environments, operationalizes AI, and delivers automation
Perma-Pipe Accelerates Growth with New U.S. Northeast Facility Investment to serve Artificial Intelligence Data Center customers, Provides Middle East Operations’ Update and Concludes the Board’s Review of Strategic Alternatives19.3.2026 14:00:00 CET | Press release
Perma-Pipe International Holdings, Inc. (the “Company”) today announced a strategic expansion initiative focused on accelerating growth through entry into the high-demand U.S. Northeast region. The Company is positioning itself to capitalize on the rapidly expanding Artificial Intelligence (“AI”)-driven data center market in both the United States and international markets while continuing to reinforce its leadership in critical infrastructure solutions. As part of this growth strategy, Perma-Pipe will prioritize investments aimed at expanding its presence in the rapidly evolving AI data center sector. The initiative reflects the Company’s long-term commitment to supporting next-generation technology infrastructure and strengthening its position in the global energy, industrial, and infrastructure markets. Expansion in the U.S. Northeast President & Chief Executive Officer, Saleh Sagr said, “We are excited to announce the expansion of our operations with a new facility in the Northeast
Armis Launches First-of-Its-Kind Benchmark Report Warning of Critical Security Gaps in AI-Native Development19.3.2026 13:00:00 CET | Press release
Research reveals 100% of leading generative AI models fail to generate secure code for critical development scenarios Armis, the cyber exposure management & security company, is warning that the rapid enterprise adoption of AI-native development is outpacing critical security safeguards, leaving organizations exposed to systemic vulnerabilities. New research from Armis Labs’ Trusted Vibing Benchmark Report, which evaluates 18 leading generative AI models across 31 test scenarios, reveals a 100% failure rate in generating secure code. These vulnerabilities are most prevalent in high-risk areas like memory buffer overflows, design file uploads and authentication systems. Therefore, organizations should immediately implement AI-native application security controls to reduce risk. “The era of vibe coding is here, but speed should not come at the cost of security,” said Nadir Izrael, CTO and Co-Founder of Armis. “Our research finds that the worst offenders are the same ones selling security
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom